
MARIA YOLANDA
DIEBOLD LUQUE
Department: Surgery, Ophthalmology, Otorhinolaryngol
Center: FAC MEDICINA
Area: Ophthalmology
Research group: Ocular Surface (GSO)
Email: yolanda.diebold@uva.es
Personal web: https://www.ioba.es/dr-yolanda-diebold/
Doctor by the Universidad de Valladolid with the thesis Superficie conjuntival humana in vitro desarrollo, caracterizacion y validacion 1997. Supervised by Dr. Margarita Calonge Cano.
My background is Biology highlighting my specific training in Histology, and Compared Organography and Physiology. I received a PhD in Ocular Cell Biology from the University of Valladolid (UVA, Spain) in 1997. In 1998 I was appointed NATO Post-Doctoral Research Fellow in Prof. Darlene A. Dartt Laboratory at the Schepens Eye Research Institute-Harvard Medical School (Boston, MA, USA) (1998-1999), in which I got expertise in animal models of ocular autoimmune inflammatory diseases. Since 2000, when I started my academic career at UVA until now, I have been working as senior independent researcher with my own continuously maintained regional, national, and international research funding. I was PI in 3 EU consortia (PI in UVa), 9 national grants, and 5 regional grants. So far, I have been awarded with four periods of six years (sexenios or tramos de investigación) (First: 1994-1999; Second: 2000-2005; Third: 2006-2011; and Fourth: 2012-2017) by the National Council for the Research Activity Assessment (CNEAI) in the Assessment of Research Activity. Nº citations and h Index (20-01-2023): A) 2,708 citations (2,554 without self-citations), h Index 25; B) 3,965 citations, 1,448 since 2018, h Index 30 (21 since 2018) and i10 Index 54 (38 since 2018) (Google Scholar); C) 2,846 citations by 2,316 documents, h Index 25 (Scopus). Publications in WOS: 138; publications in PubMed: 74. Currently, I am Associate Professor of Ocular Pathophysiology at UVA (Spain), staff member of the Consolidated Research Unit (UIC222) on Advanced Therapies for Ocular Surface Blinding Diseases, and lead the Nanomedicine Applied to Inflammatory Ocular Surface Diseases Laboratory, at IOBA. Also, I am staff member of the Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Carlos III National Institute of Health, Spain) since it was created in 2006. In addition, I have extensive experience in collaborating with the pharmaceutical industry in different projects. My research is focused on the development of complex cell-based models to study inflammatory diseases from the eye and develop advanced therapies to fight them using nanotechnology. Since 2008, I have regularly been serving as National Reviewer for the Galician Program for Research, Development and Innovation; the Spanish Research Program in Material Science; the Spanish Strategic Action in Health-Carlos III National Institute of Health; and the Spanish Agency of Quality in Research (ANEP). Also, I frequently serve as International Reviewer for different Agencies and Journals. In addition, I co-ordinate a Doctorate Programme in Visual Sciences for UVA. Along my career, I supervised 7 doctoral theses (+3 ongoing), 6 of them distinguished with the international thesis award and 3 with the "Premio Extraordinario" Award of UVa. Also, I supervised 10 Master Theses (+2 ongoing), and 10 undergraduate project thesis in Optometry (Trabajos Fin de Grado).